• Home >>
  • Pharmaceuticals and Healthcare >>
  • Ebola Virus Vaccine Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Ebola Virus Vaccine Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240282 21st May, 2018 Region : Global Pages Reports Monitor

Global Ebola Virus Vaccine market, by virus strain (Adeno virus serotype 26- Zaire Ebola Virus, Chimpanzee Adeno virus type 3-Zaire Ebola virus and Recombinant vesicular stomatitis virus-Zaire Ebola virus)


Market Scenario:
In recent years, Ebola has emerged as a major hazard to mankind. Due to the advances in globalization, the risk of a global epidemic has increased tremendously. The recent outbreak of Ebola in African region has brought the disease into the global attention. Ebola virus disease (EVD) is transmitted to humans from wild animals. Later it spreads in the human population through human-to-human transmission. One of largest causes of spread of this infection is due to the direct contact with body fluids of infected person.


The symptom of Ebola starts as a sore throat, muscle pain, headache, vomiting and high fever. It is a viral haemorrhagic fever. It means the patient bleeds internally & externally as well. The function of the liver and the kidneys is also affected by the Ebola virus.


Ebola starts out as a sore throat, muscle pain, headache, and fever. It is a viral haemorrhagic fever, which means the patient bleeds internally as well as externally. The function of the liver and the kidneys is also hampered significantly by the Ebola virus.


Ebola virus disease case fatality rate on an average is around 50%. In past outbreaks, fatality rates have varied from 25% to 90% 


At present, there is no cure for Ebola virus disease.  Symptomatic treatment for instance maintaining electrolyte balance, imagining required oxygen level and treating infectious condition might help in improving patient’s health. To prevent Ebola virus disease, most of vaccines are under different levels of developmental stage.


Key to control outbreaks successfully is community engagement. Good outbreak control is successful intervention, for instance case management, infection prevention and control practices, surveillance and contact tracing, good laboratory service, safe and dignified burials and social mobilisation.


Supportive care in the early stages of rehydration, symptomatic treatment improves the chances of survival. At present, there is as yet no licensed treatment proven to neutralize the virus, but a range of blood, immunological and drug therapies are under development.


Segmentation:
The Global Ebola Virus Vaccine market is segmented on the basis of virus strain and region.
On the basis of virus strain, the market is segmented into Adeno virus serotype 26- Zaire Ebola Virus, Chimpanzee Adeno virus type 3-Zaire Ebola virus and Recombinant vesicular stomatitis virus-Zaire Ebola virus.


Regional Analysis:
Geographically, the Global Ebola Virus Vaccine market is segregated in North America, Europe, Asia Pacific, and LAMEA (Latin America, Middle East and Africa). 


Key Players:
The major key players in Global Ebola Virus Vaccine market are: BioCryst Pharmaceutical Inc., GeoVax Labs Inc., GlaxoSmithKline plc, Mapp Biopharmaceutical, Merck & Company Inc., NewLink Genetics Corp., Novavax Inc., Regeneron Pharmaceuticals Inc., Sarepta Therapeutics Inc. and Tekmira Pharmaceuticals Therapeutics.


Segmentation:
By Virus strain
• Chemo Virus strain
• Immunosuppressant Virus strain
• Nucleoside Analogue


By Geography
• North America
• Europe
• Asia-Pacific
• LAMEA

Research Scope
The study for Global Ebola Virus Vaccine Market Survey and Trend Research 2018 will provide market size, estimates and forecast based on the following years: 
 
Historic data: 2015-16  Base Year Estimate: 2017  Forecast: 2018 to 2025
The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 
Our analyst implement, several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 

1. Introduction
1.1. Market Definition
1.2. Market Scope
2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions
3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016 

4. Virus Strain Overview
4.1. Introduction 
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. Adeno virus serotype 26- Zaire Ebola Virus
4.2.2. Chimpanzee Adeno virus type 3-Zaire Ebola virus
4.2.3. Recombinant vesicular stomatitis virus-Zaire Ebola virus
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

5. Regional Overview
5.1. Introduction
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. North America
5.2.1.1. U.S.
5.2.1.2. Canada
5.2.1.3. Mexico 
5.2.2. Europe
5.2.2.1. UK
5.2.2.2. Germany
5.2.2.3. France
5.2.2.4. Italy 
5.2.2.5. Russia
5.2.2.6. Poland
5.2.2.7. Rest of Europe
5.2.3. Asia-Pacific
5.2.3.1. China
5.2.3.2. India
5.2.3.3. Japan
5.2.3.4. Australia
5.2.3.5. South Korea
5.2.3.6. Rest of Asia-Pacific
5.2.4. LAMEA
5.2.4.1. Saudi Arabia
5.2.4.2. UAE
5.2.4.3. South Africa
5.2.4.4. Rest of LAMEA
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

6. Manufacturer/ Vendor Profile
6.1. The following attributes will be considered while profiling key manufacturers in this industry: 
6.1.1. Company Overview
6.1.2. Financial Synopsis
6.1.3. Recent Developments
6.1.4. R&D Investments (if any)
6.1.5. Strategy Overview (Analyst Perspective)
6.1.6. Type Portfolio
6.2. Companies Profiled
6.2.1. BioCryst Pharmaceutical Inc.
6.2.2. GeoVax Labs Inc.
6.2.3. GlaxoSmithKline plc.
6.2.4. Mapp Biopharmaceutical
6.2.5. Merck & Company Inc.
6.2.6. NewLink Genetics Corp.
6.2.7. Novavax Inc.
6.2.8. Regeneron Pharmaceuticals Inc.
6.2.9. Sarepta Therapeutics Inc.
6.2.10. Tekmira Pharmaceuticals
(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]